Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Dutt

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Oncotarget|December 17, 2019
Chromatin protein PC4 is downregulated in breast cancer to promote disease progression: Implications of miR-29aSweta Sikder, Sujata Kumari, Manoj Kumar, et al.
BMC Genomics|November 18, 2015
Integrated genomics approach to identify biologically relevant alterations in fewer samplesPratik Chandrani, Pawan Upadhyay, Prajish Iyer, et al.
Oncology Reports|March 31, 2023
Development and characterization of a patient‑derived orthotopic xenograft of therapy‑resistant breast cancerRamesh Butti, Prachi Kapse, Garima Bhadauriya, et al.
British Journal of Cancer|April 22, 2026
CDKN1B inactivation impacts ER signaling and drives resistance to endocrine therapy in breast cancerSuhail Ahmad, Ashwin Butle, Akshay Karn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled studyAtul Sharma, Amit Dutt Dwary, Bidhu Kalyan Mohanti, et al.
Chemistry & Biology|March 27, 2010
A structure-guided approach to creating covalent FGFR inhibitorsWenjun Zhou, Wooyoung Hur, Ultan McDermott, et al.
Heliyon|July 16, 2020
A one-step, one-tube real-time RT-PCR based assay with an automated analysis for detection of SARS-CoV-2Bhasker Dharavath, Neelima Yadav, Sanket Desai, et al.
Plos One|June 14, 2011
Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancerAmit Dutt, Alex H Ramos, Peter S Hammerman, et al.
Acta Oncologica (Stockholm, Sweden)|August 16, 2022
Lung cancer with dual <i>EGFR</i> and <i>ALK</i> driver alterations at baseline: a retrospective observational cohort studyVanita Noronha, Anuradha Chougule, Pratik Chandrani, et al.
JCO Global Oncology|July 17, 2025
Comprehensive Genomic Profiling of Anaplastic Thyroid Cancer Identifies Alterations in <i>THRA</i>, a Potential Modifier of Cellular PlasticityVaishakhi Trivedi, Vanita Noronha, Munita Bal, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Oncotarget|December 17, 2019
Chromatin protein PC4 is downregulated in breast cancer to promote disease progression: Implications of miR-29aSweta Sikder, Sujata Kumari, Manoj Kumar, et al.
BMC Genomics|November 18, 2015
Integrated genomics approach to identify biologically relevant alterations in fewer samplesPratik Chandrani, Pawan Upadhyay, Prajish Iyer, et al.
Oncology Reports|March 31, 2023
Development and characterization of a patient‑derived orthotopic xenograft of therapy‑resistant breast cancerRamesh Butti, Prachi Kapse, Garima Bhadauriya, et al.
British Journal of Cancer|April 22, 2026
CDKN1B inactivation impacts ER signaling and drives resistance to endocrine therapy in breast cancerSuhail Ahmad, Ashwin Butle, Akshay Karn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 22, 2010
Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled studyAtul Sharma, Amit Dutt Dwary, Bidhu Kalyan Mohanti, et al.
Chemistry & Biology|March 27, 2010
A structure-guided approach to creating covalent FGFR inhibitorsWenjun Zhou, Wooyoung Hur, Ultan McDermott, et al.
Heliyon|July 16, 2020
A one-step, one-tube real-time RT-PCR based assay with an automated analysis for detection of SARS-CoV-2Bhasker Dharavath, Neelima Yadav, Sanket Desai, et al.
Plos One|June 14, 2011
Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancerAmit Dutt, Alex H Ramos, Peter S Hammerman, et al.
Acta Oncologica (Stockholm, Sweden)|August 16, 2022
Lung cancer with dual <i>EGFR</i> and <i>ALK</i> driver alterations at baseline: a retrospective observational cohort studyVanita Noronha, Anuradha Chougule, Pratik Chandrani, et al.
JCO Global Oncology|July 17, 2025
Comprehensive Genomic Profiling of Anaplastic Thyroid Cancer Identifies Alterations in <i>THRA</i>, a Potential Modifier of Cellular PlasticityVaishakhi Trivedi, Vanita Noronha, Munita Bal, et al.
Pageof 9